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Abstract: The present study was aimed at determining the effectiveness of nitric 
oxide synthase (NOS) inhibitors: N-nitro-L-arginine methyl ester, 7-nitroinda-
zole and aminoguanidine in modulating the toxicity of AlCl3 on superoxide 
production and the malondialdehyde concentration of Wistar rats. The animals 
were sacrificed 10 min and 3 days after the treatment and the forebrain cortex 
was removed. The results show that AlCl3 exposure promotes oxidative stress 
in different neural areas. The biochemical changes observed in the neuronal 
tissues show that aluminum acts as pro-oxidant, while NOS inhibitors exert an 
anti-oxidant action in AlCl3-treated animals. 
Keywords: aluminum; forebrain cortex; NOS inhibitors; superoxide production; 
lipid peroxidation. 
INTRODUCTION 
Aluminum has the ability to produce neurotoxicity by many mechanisms. In 
addition to the promotion of insoluble beta-amyloid (A beta) and hyperphospho-
rylated tau protein formation and accumulation, Al can alter neuronal signal trans-
duction pathways associated with glutamate receptors.1,2 In cerebella neurons in 
culture, long term-exposure to Al added in vitro impaired the glutamate (Glu)–ni-
tric oxide (NO)–cyclic GMP (cGMP) pathway, reducing the glutamate-induced 
activation of NO synthase (NOS) and NO-induced activation of the cGMP 
generating enzyme, guanylate cyclase. These findings suggest that the 
impairment of the Glu–NO–cGMP pathway in the brain may be responsible for 
some of the neurological alteration induced by Al.3–5 
Free radicals (oxidative toxins) have been implicated in the destruction of 
cells through the process of lipid peroxidative damage of the cell membranes. 
Aluminum has been shown to alter the Ca2+ flux and homeostasis, and facilitate 
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peroxidation of membrane lipids.6 After exposure to Al, a statistically significant 
increase in malondialdehyde (MDA), an index of lipid peroxidation, was ob-
served.7,8 
Molecular oxygen is the primary biological electron acceptor that plays vital 
roles in fundamental cellular functions. However, the beneficial properties of O2 
are accompanied by the inadvertent formation of reactive oxygen species (ROS), 
such as superoxide ( −2O ), hydrogen peroxide (H2O2), and hydroxyl radicals 
(OH•).9,10 Evidence is being amassed that iron (Fe) accumulates in the brain and 
catalyzes −2O  formation, which reacts with NO to form the very harmful peroxy-
nitrite ion (ONOO–), that nitrates tyrosine residues to form nitrotyrosine.11 
The NO-synthesizing enzyme NOS is present in the mammalian brain in 
three different isoforms, two constitutive enzymes (i.e., neuronal nNOS and en-
dothelial eNOS) and one inducible enzyme (iNOS). All three isoforms are aber-
rantly expressed after Al intoxication giving rise to elevated levels of NO, which 
is apparently involved in neurodegeneration by various different mechanisms, in-
cluding oxidative stress and activation of intracellular signaling mechanisms.12 
Cell death and changes in neurite morphology were partly reduced when NO 
production was inhibited by NOS inhibitors.13–17 In view of the above, the pre-
sent study was undertaken to examine whether −2O  production and MDA con-
centration after receiving intracerebral injections of AlCl3 can be modulated by 
the co-administration with various NOS inhibitors: non-specific inhibitor NOS 
(N-nitro-L-arginine methyl ester – L-NAME) and specific inhibitors: neuronal 
NOS inhibitor (7-nitroindazol – 7-NI) and inducible NOS inhibitor (aminoguani-
dine – AG).18–20 
EXPERIMENTAL 
Materials and animals 
The employed chemicals, all analytical grade, were purchased from Sigma (St. Louis, 
MO, USA). All drug solutions were prepared on the day of the experiment. 
Male adult Wistar rats with a body mass 500 ± 50 g were used for the experiments. 
Groups of two or three rats per cage (Erath, FRG), were housed in an air-conditioned room at 
a temperature of 23±2 °C with 55±10 % humidity and with lights on 12 h/day (07.00–19.00 
h). The animals were given a commercial rat diet and tap water ad libitum. The animals used 
for the procedure were treated in strict accordance with the NIH Guide for Care and Use of 
Laboratory Animals (1985). 
Experimental procedure 
For biochemical analysis, the rats were divided into eight basic groups (according to 
drug treatment). Each basic group consisted of two different subgroups (according to survival 
times – 10 min and 3 days) and each subgroup consisted of 10 animals. Animals were anes-
thetized by intraperitoneal injections of sodium pentobarbital (0.04 g/kg b.w.). Using a stereo-
taxic instrument for small animals, the chemicals were administered by a Hamilton microsy-
ringe and injected into the CA1 sector of the hippocampus (coordinates: 2.5 A; 4.2 L; 2.4 
V).21 The NOS inhibitors (L-NAME, 7-NI or AG) were immediately applied before a neuro-
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toxin/saline solution. In all treated animals, the injected intracerebral volume was 10 µl (Table I) 
and it was always injected into the same left side. All animals were decapitated and the heads 
were immediately frozen in liquid nitrogen and stored at –70 °C until use. Then the ipsilateral 
and contralateral forebrain cortex (FC) was quickly isolated and homogenized in ice-cold 
buffer containing 0.25 M sucrose, 0.10 mM EDTA, 50 mM K-Na phosphate buffer, pH 7.2. 
The homogenates were centrifuged twice at 1580 rpm for 15 min at 4 °C. The supernatant (crude 
mitochondrial fraction) obtained by this procedure was then frozen and stored at –70 °C.22 
Table I. All the experimental animal groups with the applied dosage for the appropriate treat-
ment 
Number Group Dosage 
1 Control 0.9% saline solution 
2 AlCl3 3.7×10-4 g/kg b.w. dissolved in 0.010 ml of deionizied water 
3 L-NAME +AlCl3 1×10-4 g dissolved in saline solution + AlCl3 
4 7-NI+AlCl3 1×10-4 g dissolved in olive oil + AlCl3 
5 AG+AlCl3 1×10-4 g dissolved in saline solution + AlCl3 
6 L-NAME 1×10-4 g dissolved in saline solution + saline solution 
7 7-NI 1×10-4 g dissolved in saline solution + saline solution 
8 AG 1×10-4 g dissolved in saline solution + saline solution 
Biochemical analysis 
The superoxide anion content was determined through the reduction of nitro blue tetra-
zolium (Merck, Darmstadt, Germany) in a nitrogen saturated alkaline medium. Kinetic ana-
lysis was performed at 550 nm.23 
The lipid peroxidation index was measured as the quantity of produced malondialdehyde 
(MDA). Thiobarbituric acid reagent (TBAR–15 % trichloroacetic acid (Merck, Darmstadt) + 
+ 0.375 % TBA + 0.25 % mol HCl) reacted with MDA, which had been produced from po-
lysaturated fatty acids in the process of peroxidation. The product of reaction – MDA, was 
measured spectrophotometrically at 533 nm.24 
The protein content in the rat brain homogenates (forebrain cortex-FC, ipsilateral and 
contralateral) was measured by the Lowry method using bovine serum albumin (Sigma) as the 
standard.25 
Data presentation and analysis  
Statistical analysis was performed using the statistical software program, Statistic 5.0 for 
Windows. Descriptive data are expressed as the mean±standard deviation (SD). The statistical 
significance was determined as p < 0.05 using either the Student’s t-test or ANOVA followed 
by the Tukey’s t-test. 
RESULTS 
Superoxide production in the rat forebrain cortex (FC) 
The −2O  levels (μM red. NBT min–1 mg–1 proteins) bilaterally in the rat FC 
homogenates at 10 min (Fig. 1A) and 3 days (Fig. 1B) after the treatment are 
presented in Fig. 1. At the early tested time (10 min), AlCl3 injection resulted in 
higher levels of −2O  production in the contralateral FC, compared to the control 
animals (p < 0.05). Also, 7-NI + AlCl3 application, as well as L-NAME injection 
and AG injection, resulted in an increase in the production of −2O  bilaterally in 
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the FC after 10 min, compared to the control groups. However, after 3 days, 
L-NAME + AlCl3 and 7-NI + AlCl3 injection resulted in lower levels of −2O  pro-
duction bilaterally in the same brain structure, compared to the control groups. At 
10 min after 7-NI + AlCl3 application, the −2O  levels showed increase in the 
ipsilateral FC, compared with the AlCl3-treated animals. L-NAME application 
resulted in an increase of the −2O  levels ipsilaterally in the FC after 10 min and 
bilaterally in this brain structure after 3 days, compared to the L-NAME + AlCl3-
-treated groups. Also, AG injection resulted in an increase of −2O  production in 
the ipsilateral FC after 10 min, compared to the AG + AlCl3-treated group. How-
ever, 7-NI injection resulted in a decrease of −2O  production bilaterally in the FC 





Fig. 1. The effect of intrahippocampal drug injection on −2O  production (μM red. NBT/min/mg 
protein) in the rat ipsilateral and contralateral FC at different survival times – 10 min (A) and 
3 days (B) after treatment. Data are means ±SD of 10 animals. *A statistically significant 
difference between the treated (AlCl3-, NOS inhibitors + AlCl3- and NOS inhibitors-treated) 
and the control (sham-operated) animals (p < 0.05). •A statistically significant difference 
between the NOS inhibitors + AlCl3-treated and the AlCl3-treated animals (p < 0.05). 
♦A statistically significant difference between the NOS inhibitors-treated and 
the NOS inhibitors + AlCl3-treated animals (p < 0.05). 
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Malondialdehyde concentration in the rat forebrain cortex (FC) 
The MDA concentration (nM MDA h–1 mg–1 proteins) in the ipsilateral and 
contralateral FC homogenates at 10 min (Fig. 2A) and 3 days (Fig. 2B) after the 
treatment are shown in Fig. 2. Ten minutes after the injection of AlCl3 injection 
and of L-NAME, the MDA concentration was bilaterally increased in the FC 
compared to controls, with the difference being statistically significant (Student’s 
t-test; p < 0.05). Also, in the same brain structure, after 3 days, the MDA concen-
tration was increased bilaterally after 7-NI+AlCl3 and AG injection, as well as 





Fig. 2. The effect of intrahippocampal drug injection on the MDA concentration (nM MDA/h/mg 
protein) in the rat ipsilateral and contralateral FC at different survival times – 10 min (A) and 
3 days (B) after treatment. Data are means ±SD of 10 animals. *A statistically significant 
difference between treated (AlCl3-, NOS inhibitors + AlCl3- and NOS inhibitors-treated) and 
the control (sham-operated) animals (p < 0.05). •A statistically significant difference between 
the treated (NOS inhibitors + AlCl3- and NOS inhibitors-treated) and the AlCl3-treated 
animals (p < 0.05). ♦A statistically significant difference between the NOS inhibitors-treated 
and the NOS inhibitors + AlCl3-treated animals (p < 0.05).  
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Ten minutes after L-NAME + AlCl3 and 7-NI + AlCl3 injection, lower MDA 
concentrations were measured in the ipsilateral FC, and after AG + AlCl3 injec-
tion in the ipsilateral and contralateral FC, compared to the AlCl3-treated group. 
However, after 3 days, 7-NI + AlCl3 injection resulted in a higher MDA concen-
tration bilaterally in the same brain structure, compared to the AlCl3-treated group. 
At the early tested time (10 min), L-NAME application resulted in an increase in 
the MDA concentration bilaterally in the FC, compared with the AlCl3-treated 
animals, as well as compared to the L-NAME + AlCl3-treated groups (p < 0.05). 
Also, AG injection resulted in an increase in the MDA concentration in the ipsi-
lateral FC after 3 days, compared to the AG + AlCl3-treated group. However, 7-NI 
injection resulted in a decrease in the MDA concentration bilaterally in the FC 
after 10 min, compared to the 7-NI + AlCl3-treated group (Fig. 2). 
DISCUSSION 
The application of AlCl3 to the CA1 sector of the hippocampus resulted in a 
significant increase in −2O  production and the MDA concentration in the FC. 
This suggests that inhibition of NOS by L-NAME, 7-NI or AG can modulate 
AlCl3 poisoning and, therefore, may limit the retrograde and anterograde spread 
of toxicity. 
In this study, AlCl3 application produced a rapid (within 10 min) increase in 
−
2O  production contralaterally in the FC, compared to the control (Fig. 1A). 
Literature data suggest that Al is suspected to be associated with oxidative stress, 
possibly due to the pro-oxidant properties of A beta in the senile plaques.26,27 
The underlying mechanism by which this occurs is not well understood although 
interactions between amyloid and Fe have been proposed. The presence of low 
molecular weight Fe compounds can stimulate free radical production in the 
brain. Both Al and A beta can potentiate free radical formation by stabilizing Fe 
in its more damaging ferrous (Fe2+) form, which can promote the Fenton reac-
tion. The rate at which Fe2+ is spontaneously oxidized to Fe3+ was significantly 
slower in the presence of Al salts.28 
There are several lines of evidence that show a key role of ROS in both 
intracellular signaling and intracellular communication, processes involved in 
maintaining homeostasis. Some experimental data indicate that ROS-mediated 
lipid peroxidation, protein oxidation and oxidative alterations to nucleic acids are 
crucial events of the unfavorable actions of ROS.29,30 Lipid peroxidation is a 
measure of tissue destruction. Literature data suggest that Al may facilitate in-
creases in intracellular Ca2+ and ROS, and potentially contribute to neurotoxicity 
induced by other neurotoxicants.6 In this study, it was shown that 10 min after 
intrahippocampal AlCl3 injection, the application of a neurotoxicant produced an 
increase in the MDA concentration bilaterally in the FC, compared to control ani-
mals (Fig. 2A). 
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Neuropharmacological data indicate that A beta toxicity is mediated by an 
excitotoxic cascade involving blockage of astroglial glutamate uptake, sustained 
activation of NMDA receptors and an overt intracellular Ca2+ influx.31 These 
changes are associated with increased NOS activity in cortical target areas that 
may directly lead to the generation of free radicals. A sustained overproduction 
of NO via NOS expression may be responsible, at least in part, for some of the 
neurodegenerative changes caused by stress and support a possible role for NOS 
inhibitors in this situation.32 
Decreased −2O  production bilaterally in the FC at 3 days in the L-NAME + 
+ AlCl3 group and the 7-NI + AlCl3 group compared to the controls (Fig. 1B), 
along with decreased SOD activity (results not shown) confirm the achieved anti-
-oxidative defense. 
In addition, the decreased MDA concentration ipsilaterally in the same brain 
structure at 10 min in the NOS inhibitors + AlCl3 groups, compared to the AlCl3-
-treated animals, (Fig. 2A), suggests activation of the anti-oxidative system, re-
sulting in an aggressive blockage of the oxidative mechanisms initiated by neuro-
toxicant application. 
The significant increase in −2O  production after L-NAME and after AG in-
jection (at 10 min bilaterally in the FC, compared to the controls), which corre-
lates with unchanged −2O  levels after 7-NI application in the same brain structure 
(Fig. 1A), indicates the permanent and long-lasting effect of nNOS blocking at 
the early tested time. These findings suggest that treatment with 7-NI leads to the 
protection of brain neurons against neuronal injuries by impairment of cellular 
energy metabolism and oxidative stress.33–35 
The present data, which indicates an increased MDA concentration 10 min 
after L-NAME application bilaterally in the FC compared to the controls (Fig. 
2A), suggests that NOS inhibition exhibits protective effects for cellular mem-
brane. This only occurs during the presence of oxidative stress caused by AlCl3, 
meaning that peroxidation after L-NAME application is not developed through 
NO, but through the creation of •OH from −2O  and H2O2.36 
In addition, it was shown in this study that L-NAME injection after 10 min 
produced an increase in the MDA concentration, compared to the L-NAME + 
+ AlCl3-treated group (Fig. 2A). It is known37 that glutamate excitotoxicity, 
oxidative stress, and mitochondrial dysfunctions are common features leading to 
neuronal death after Al intoxication. Nitric oxide, alone or in cooperation with 
−
2O  and ONOO–, is emerging as a predominant effector of neurodegeneration. 
CONCLUSIONS 
In conclusion, the present data revealed that NO is included in the toxicity 
induced by AlCl3 application in the CA1 hippocampal sector, resulting in both 
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temporal and spatial spreading of damage to the FC, so that NOS inhibitors 
(L-NAME, 7-NI, AG) could have potentially beneficial effects. 
И З В О Д  
ЕФЕКТИ РАЗЛИЧИТИХ ИНХИБИТОРА АЗОТ-ОКСИД-СИНТАЗЕ НА 
ОШТЕЋЕЊЕ НЕУРОНА ИЗАЗВАНО AlCl3 
ИВАНА СТЕВАНОВИЋ1, МАРИНА ЈОВАНОВИЋ1, АНКИЦА ЈЕЛЕНКОВИЋ2, 
МИОДРАГ ЧОЛИЋ1 и МИЛИЦА НИНКОВИЋ1 
1Vojnomedicinska akademija, Institut za medicinska istra`ivawa, Crnotravska 17, Beograd i 
2Institut za biolo{ka istra`ivawa Beograd 
У експерименту је одређивана ефикасност инхибитора азот-оксид-синтазе (NOS): 
метил-естра N-нитро-L-аргинина, 7-нитроиндазола и аминогванидина у модулацији токсич-
ности AlCl3 на стварање супероксидног анјона и концентрацију малондиалдехида код Wistar пацова. Животиње су жртвоване 10 min и 3 дана након третмана и изолована је кора великог 
мозга. Резултати показују да излагање AlCl3 покреће оксидативни стрес у различитим мож-даним регионима. Биохемијске промене описане у неуронском ткиву показују да алумини-
јум делује као про-оксидант, док инхибитори NOS имају антиоксидативно дејство код живо-
тиња третираних AlCl3. 
(Примљено 1. октобра, ревидирано 9. децембра 2008) 
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